The case of a CD74-ROS1 fusion in a 64-year-old inflammatory breast cancer patient (IBC) was found through NGS as a combination of CD74 exon 7 and ROS1 exon 34, which may have contributed to rapid disease progression as they died 18 months after tumor discovery [55]. The gene discussed is CD74; the disease is neoplasm.